Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Research on vaccines published by D. Acosta et al
June 25th, 2008
According to recent research from Montevideo, Uruguay, "Leucyl aminopeptidases (LAP) from different parasitic organisms are attracting attention as relevant players in parasite biology, and consequently being considered as candidates for drug and vaccine design. In fact, the highest protection level achieved in ruminant immunization by a native antigen was previously reported by us, using a purified LAP as immunogen in a sheep trial against fasciolosis." "Here, we report the cloning of a full-length cDNA from adult F hepatica encoding a member of the M 17 family of LAP (FhLAP) and functional expression and characterization of the corresponding enzyme. FhLAP was closely...
Source: Vaccine Weekly (2008-06-25)
|
